Michelle M. Mello's Testimony Before the U.S. Senate Committee on Finance
In this testimony presented to the U.S. Senate Committee on Finance, Michelle M. Mello provides recommendations on how Congress can support healthcare organizations and health insurers navigating the uncharted territory of AI tools by imposing some guardrails while allowing the rules to evolve with the technology.
In collaboration with
Related Publications
Designing Loyalty: AI Agents and Conflicts of Interest
This brief examines the conflict-of-interest risks posed by AI agents and calls for imposing a duty of loyalty on developers and deployers.
This brief examines the conflict-of-interest risks posed by AI agents and calls for imposing a duty of loyalty on developers and deployers.
Regulating Data Brokers in the Age of AI: A California Case Study
This brief assesses data broker compliance with California privacy laws and calls for more stringent consumer protections.
This brief assesses data broker compliance with California privacy laws and calls for more stringent consumer protections.
This brief highlights the emergence of world models and outlines a first-of-its-kind governance and policy agenda for the technology.
This brief highlights the emergence of world models and outlines a first-of-its-kind governance and policy agenda for the technology.
Operationalizing Real-Time Monitoring of Clinical AI
This brief demonstrates how real-time monitoring can address critical gaps in the oversight of radiological AI tools.
This brief demonstrates how real-time monitoring can address critical gaps in the oversight of radiological AI tools.